Introduction
The pathogenic yeast, Candida albicans, is increasingly difficult to treat due to resistance against known anti-fungal drugs. Vaccines based on the immunogenic (β1-2)-mannan of the C. albicans cell wall may offer an alternative treatment. NMR and immunochemical data presented below provide evidence that a surprisingly small epitope may be a candidate for creating a viable conjugate vaccine. The synthetic di-to hexasaccharides 1-5 were studied by NMR ( Figure 1 ) and a detailed conformational analysis for pentasaccharide 4 is presented here. Figure 3 Computer-generated global minimum structure of 4 consistent with NMR data. Results NOE-based distances for pentasaccharide 4 are shown in Figure 2 with MD calculated average distances, in parentheses. Other oligosaccharides exhibited similar n→(n+1), n→(n+2) and n→(n+3) effects. In addition to the typical inter-residue NOE, we observed and quantified a total of 12 NOE interactions (3 per sugar pair). These NOEs and associated inter-proton distances can only be econciled with a highly organized, helical conformation ( Figure 3 ) with a 3 to 4 residue repeat. r
Immunochemistry of the C. albicans β-mannan Di-and trisaccharides 1 and 2 are significantly better inhibitors than larger tetra-to hexasaccharides (3-5) with two monoclonal antibodies (MAbs) (Figure 4 ). Both MAbs confer protection in mouse models of infection. This size specificity contrasts with the typical pattern, where activity steadily increases and plateaus at about the size of a hexamer [2] . Our immunochemical findings correlate with the ordered conformation of the β1,2-linked mannopyranans and suggest the design of simple anti-C. albicans conjugate vaccines. Preliminary data substantiate the proposition [3] that short oligosaccharides coupled to protein can provide an antigen capable of inducing protection against C. albicans. After three injections with trisaccharide 2 conjugated to BSA, a strong antibody response specific for the C. albicans β-mannan was detected ( Figure 5 ).
Conclusions
The helical propensity of β1,2-linked mannopyranans creates a small epitope that is recognized by MAbs that are protective ♦ ♦ ♦ A trisaccharide conjugate vaccine induces polyclonal antibodies specific for the protective β-mannan cell wall antigen A conjugate vaccine may protect individuals at risk of developing serious conditions due to C. albicans.
